Cargando…

Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study

BACKGROUND: The interplay between genetic susceptibility and carcinogenic exposure is important in the development of haematopoietic malignancies. EPHX1, NQO1 and PON1 are three genes encoding proteins directly involved in the detoxification of potential carcinogens. METHODS: We have studied the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Conesa-Zamora, Pablo, Ruiz-Cosano, Javier, Torres-Moreno, Daniel, Español, Ignacio, Gutiérrez-Meca, María D, Trujillo-Santos, Javier, Pérez-Ceballos, Elena, González-Conejero, Rocío, Corral, Javier, Vicente, Vicente, Pérez-Guillermo, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649938/
https://www.ncbi.nlm.nih.gov/pubmed/23651475
http://dx.doi.org/10.1186/1471-2407-13-228
_version_ 1782269041559207936
author Conesa-Zamora, Pablo
Ruiz-Cosano, Javier
Torres-Moreno, Daniel
Español, Ignacio
Gutiérrez-Meca, María D
Trujillo-Santos, Javier
Pérez-Ceballos, Elena
González-Conejero, Rocío
Corral, Javier
Vicente, Vicente
Pérez-Guillermo, Miguel
author_facet Conesa-Zamora, Pablo
Ruiz-Cosano, Javier
Torres-Moreno, Daniel
Español, Ignacio
Gutiérrez-Meca, María D
Trujillo-Santos, Javier
Pérez-Ceballos, Elena
González-Conejero, Rocío
Corral, Javier
Vicente, Vicente
Pérez-Guillermo, Miguel
author_sort Conesa-Zamora, Pablo
collection PubMed
description BACKGROUND: The interplay between genetic susceptibility and carcinogenic exposure is important in the development of haematopoietic malignancies. EPHX1, NQO1 and PON1 are three genes encoding proteins directly involved in the detoxification of potential carcinogens. METHODS: We have studied the prevalence of three functional polymorphisms affecting these genes rs1051740 EPHX1, rs1800566 NQO1 and rs662 PON1 in 215 patients with lymphoma and 214 healthy controls. RESULTS: Genotype frequencies for EPHX and NQO1 polymorphisms did not show any correlation with disease. In contrast, the GG genotype in the PON1 polymorphism was found to be strongly associated with the disease (15.3% vs. 4.7%; OR = 3.7 CI (95%): 1.8-7.7; p < 0.001). According to the pathological diagnosis this association was related to follicular (p = 0.004) and diffuse large B-cell (p = 0.016) lymphomas. CONCLUSIONS: Despite the fact that further confirmation is needed, this study shows that the PON1 GG genotype in rs662 polymorphism could be a risk factor for B-cell lymphomas.
format Online
Article
Text
id pubmed-3649938
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36499382013-05-10 Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study Conesa-Zamora, Pablo Ruiz-Cosano, Javier Torres-Moreno, Daniel Español, Ignacio Gutiérrez-Meca, María D Trujillo-Santos, Javier Pérez-Ceballos, Elena González-Conejero, Rocío Corral, Javier Vicente, Vicente Pérez-Guillermo, Miguel BMC Cancer Research Article BACKGROUND: The interplay between genetic susceptibility and carcinogenic exposure is important in the development of haematopoietic malignancies. EPHX1, NQO1 and PON1 are three genes encoding proteins directly involved in the detoxification of potential carcinogens. METHODS: We have studied the prevalence of three functional polymorphisms affecting these genes rs1051740 EPHX1, rs1800566 NQO1 and rs662 PON1 in 215 patients with lymphoma and 214 healthy controls. RESULTS: Genotype frequencies for EPHX and NQO1 polymorphisms did not show any correlation with disease. In contrast, the GG genotype in the PON1 polymorphism was found to be strongly associated with the disease (15.3% vs. 4.7%; OR = 3.7 CI (95%): 1.8-7.7; p < 0.001). According to the pathological diagnosis this association was related to follicular (p = 0.004) and diffuse large B-cell (p = 0.016) lymphomas. CONCLUSIONS: Despite the fact that further confirmation is needed, this study shows that the PON1 GG genotype in rs662 polymorphism could be a risk factor for B-cell lymphomas. BioMed Central 2013-05-07 /pmc/articles/PMC3649938/ /pubmed/23651475 http://dx.doi.org/10.1186/1471-2407-13-228 Text en Copyright © 2013 Conesa-Zamora et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Conesa-Zamora, Pablo
Ruiz-Cosano, Javier
Torres-Moreno, Daniel
Español, Ignacio
Gutiérrez-Meca, María D
Trujillo-Santos, Javier
Pérez-Ceballos, Elena
González-Conejero, Rocío
Corral, Javier
Vicente, Vicente
Pérez-Guillermo, Miguel
Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study
title Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study
title_full Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study
title_fullStr Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study
title_full_unstemmed Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study
title_short Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study
title_sort polymorphisms in xenobiotic metabolizing genes (ephx1, nqo1 and pon1) in lymphoma susceptibility: a case control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649938/
https://www.ncbi.nlm.nih.gov/pubmed/23651475
http://dx.doi.org/10.1186/1471-2407-13-228
work_keys_str_mv AT conesazamorapablo polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy
AT ruizcosanojavier polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy
AT torresmorenodaniel polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy
AT espanolignacio polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy
AT gutierrezmecamariad polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy
AT trujillosantosjavier polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy
AT perezceballoselena polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy
AT gonzalezconejerorocio polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy
AT corraljavier polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy
AT vicentevicente polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy
AT perezguillermomiguel polymorphismsinxenobioticmetabolizinggenesephx1nqo1andpon1inlymphomasusceptibilityacasecontrolstudy